Latest medical news · page 73

Hyponatremia Correction: How Fast Is Too Fast?

Dr. Centor discusses hyponatremia correction rates with Dr. Dustin Mark.

Episode 247 -- February 2026 -- Part 1 AFP: American Family Physician

Menopause management (1:30), wheezing in children (4:00), prevention of nonsteroidal anti-inflammatory drug–induced ulcers (8:20), infective endocarditis (11:00), acute migraine treatment (17:10), and colchicine for secondary prevention of cardiovascular disease (20:40).

Type 1 Diabetes: Diagnosis and Management

Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content: Type 1 Diabetes

Extensively drug-resistant Salmonella outbreak linked to moringa powder capsules

Three people have been hospitalized, and no deaths have been reported.

Pharmaceutical Pricing: JAMA Talks With Mark Cuban

Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and opaque pricing practices that shape how most Americans access prescription drugs. Hear why he thinks doctors are the good guys in a broken system. Related Content: Pharmaceutical Pricing—JAMA Talks With Mark Cuban

Medications for Opioid Use Disorder, Withdrawal, and Overdose

Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy, safety, and practical considerations of treating patients with medications for opioid use disorder, opioid withdrawal, and opioid overdose. Related Content: Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose

NEJM This Week — February 12, 2026

This week includes studies on promising new therapies for IgA nephropathy, evolving antithrombotic strategies after coronary stenting, and the inciting antigen in rare vaccine-related clotting syndromes. We review the urgent challenge of mucormycosis and follow the case of a young woman with headaches and hypertension. We discuss human-subjects research. Perspectives examine rural health, data interoperability, drug labels in the courts, and a pediatrician’s dilemma.

Level 2 - Chikungunya in Bolivia

There is an outbreak of chikungunya in Santa Cruz and Cochabamba Departments, Bolivia. You can protect yourself by preventing mosquito bites.

FDA expands Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Merck Sharp Dohme

FDA expands Keytruda (pembrolizumab) approval

Efficacy supplement (new or revised indication). solution, intravenous. Sponsor: Merck Sharp Dohme

Level 2 - Chikungunya in Seychelles

There is an outbreak of chikungunya in Seychelles. You can protect yourself by preventing mosquito bites.

Black family medicine leaders map community-building and leadership

Episode 71 - Helena de Carvalho Gomes - Cervical Cancer Then & Now - The Path to Elimination

In this episode of ECDC On Air, we speak with ECDC's Helena de Carvalho Gomes - Deputy Head of Unit for Scientific Evidence and Communication, and former clinician in obstetrics and gynaecology, about the role of human papillomavirus (HPV) in cervical cancer and how vaccination and screening can prevent the disease. Drawing on her clinical experience, she reflects on changes in cervical cancer prevention over the past 25 years and on the impact of HPV vaccination and screening in reducing pre-cancerous lesions and cancer risk among women.We also discuss why sustained vaccination programmes and…

NEJM This Week — February 5, 2026

This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.

Black History Month Q&A: Diversity, mentorship and representation in medicine

Residency tips: Making the couples match work for both partners

The Role of Corticosteroids in Severe Pneumonia

Dr. Centor discusses the role of corticosteroids in the treatment of community-acquired pneumonia with Dr. Michael Klompas.

Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal

Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma

Episode 246 -- January 2026 -- Part 2 AFP: American Family Physician

Endometriosis-associated pain (1:30), HIV-associated complications (3:30), glucagon-like peptide-1 receptor agonists for obesity in adolescents (7:40), discontinuing antihypertensives (12:40), vertebral compression fractures (14:40), and buprenorphine dosage for opioid use disorder (18:30).

NEJM This Week — January 29, 2026

This week, we explore new therapies to reduce pancreatitis risk in severe hypertriglyceridemia, advances in breast cancer treatment, and long-term results of gene therapy for hemophilia B. We discuss vision-threatening vascular emergencies, the mental health effects of firearm injury on families, and care for peripheral artery disease. We also follow a revealing diagnostic case in an older woman with respiratory failure. Perspectives reflect on hypertension control, immunization access, chronic disease policy, and on the inherited risk of disease.

IgA Nephropathy in Adults

IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: IgA Nephropathy in Adults

Level 2 - Clade II Monkeypox in Ghana and Liberia

There are outbreaks of clade II monkeypox in Ghana and Liberia, where monkeypox is endemic. Country List : Ghana, Liberia

FDA expands Afrezza (insulin recombinant human) approval

Efficacy supplement (new or revised indication). powder, inhalation. Sponsor: Mannkind

AAFP residency initiative drives changes for 2027 Match